Field Study of a Novel Synthetic Peptide Immunotherapy in Cat Allergic Patients

The objective of this multi-center, pivotal registration study was to establish the efficacy and safety of a specific T cell immunoregulatory synthetic peptide therapy (Cat-PAD). A promising therapeutic profile had been demonstrated in the preceding clinical investigative program. (Source: Journal of Allergy and Clinical Immunology)

from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader http://bit.ly/2GvMjFV